ライフサイエンスコーパス: NHANES

1 NHANES (National Health and Nutrition Examination Survey

2 NHANES cross-sectional data (2009-2012) were analyzed in

3 NHANES is a nationally representative survey of the noni

4 NHANES is a series of cross-sectional, nationally repres

5 NHANES measures hundreds of chemical biomarkers in sampl

6 NHANES responds to evolving data needs, as feasible, in

7 NHANES, however, excludes several high-risk populations

8 he variability in geometric means across 106 NHANES chemicals for all the demographic groups, includi

9 d Nutrition Examination Survey 1988 to 1994 (NHANES III).

10 calculated for participants in the 1999-2002 NHANES.

11 orptiometry data obtained from the 1999-2004 NHANES were analyzed for 13,236 subjects aged >/=18 y (m

12 indoor allergens and glaucoma for 2005-2006 NHANES participants.

13 ns in adults aged 19-70 y from the 2005-2006 NHANES were used (n = 3871).

14 For the 2007-2008 NHANES data, the ANN model assigned 7 out of 1998 specim

15 rediabetes who participated in the 2005-2010 NHANES cycles.

16 673 adults who participated in the 2007-2010 NHANES-a cross-sectional nationally representative sampl

17 1998 specimens (0.35%) and for the 2013-2014 NHANES data 12 out of 2906 specimens (0.41%) to the crud

18 A total of 5746 NHANES participants had optic images originally graded.

19 Of the 19 613 NHANES participants, we identified 31 participants carry

20 Results: Study participants included 6489 NHANES participants with a mean (SD) age of 13.6 (3.6) y

21 with the US population (represented by 5,769 NHANES participants), the 12,280 Health eHeart participa

22 Overall, 9608 NHANES participants representing 67.9 million adults wer

23 in male and female children and adolescents: NHANES 2011-2012.

24 n a prospective cohort of healthy US adults (NHANES III; 1998-1994).

25 EI-2010 than that of other groups across all NHANES cycles.

26 We analyzed NHANES data from 2005 to 2008 to determine the prevalenc

27 mination Survey (NHANES) III (1988-1994) and NHANES 9908 (1999-2008) with PbA data from the U.S. Envi

28 Between NHANES 2001-2002 and NHANES 2009-2010, LSGMs of sCOT levels had changed -25%

29 surfaces within a hierarchical cluster; and NHANES, National Health and Nutrition Examination Survey

30 nt" and "breakfast" patterns in Homescan and NHANES, "ready-to-eat meals/fast-food" and "prudent/snac

31 utrition Examination Survey (NHANES) III and NHANES 1999 to 2004.

32 monocular fundus photographs using MESA and NHANES definitions, respectively, including 47.0% (95% C

33 monocular fundus photographs using MESA and NHANES definitions, respectively.

34 nd Nutrition Examination Survey (NHANES) and NHANES III (1988-1994).

35 Relating data from the IRIS Registry and NHANES could be a novel method for assessing ophthalmic

36 clined from 2007 to 2010 in Project Viva and NHANES.

37 After imputing missing data and applying NHANES sampling weights, we extrapolated the results to

38 Between NHANES 2001-2002 and NHANES 2009-2010, LSGMs of sCOT lev

39 ght men did not change significantly between NHANES I and III, it did decrease significantly among se

40 ration distribution of each food consumed by NHANES participants as the 4 iodine concentration summar

41 vast majority of the chemicals monitored by NHANES, the resulting list of associations is appropriat

42 ood codes corresponding to foods reported by NHANES participants were matched to NSRI and Health Cana

43 Exposures: Calendar time, as represented by NHANES cycle.

44 U.S. residents in the population sampled by NHANES have chronic HCV infection, about 500,000 fewer t

45 In the validation cohort (NHANES III), the equation provided for prognostic inform

46 in 12-19 year old adolescents when comparing NHANES 2007/08 with 2003/04; while for subjects over the

47 Calendar year, as represented by continuous NHANES cycle.

48 ealth and Nutrition Examination Survey data (NHANES, 2001-2012), we developed a potency-weighted sum

49 e with urinary concentrations of DCPs during NHANES 2003-2010.

50 tion in nutrition assistance program at each NHANES cycle.

51 o estimate the prevalence of use within each NHANES cycle, and trends were evaluated across cycles.

52 Within each NHANES cycle, use of prescription drugs in the prior 30

53 The final NHANES examination response rate for adults aged 20-69 y

54 of extent and severity of periodontitis for NHANES data (>/= 2 interproximal sites with >/= 3 mm att

55 UIC values and dietary intakes reported for NHANES participants who provided both types of data-and

56 o impute ABP-defined hypertension status for NHANES participants and estimate MHT prevalence among th

57 US adults (n = 4840) from NHANES (2003-2006) wore an accelerometer for </=7 d and

58 red by dual-energy X-ray absorptiometry from NHANES.

59 furans and LTL among 1,330 U.S. adults from NHANES 2001-2002.

60 risk factors were estimated using data from NHANES (National Health and Nutrition Examination Survey

61 e describes the NHANES program and data from NHANES 1999-2010 on young children that are relevant for

62 imated with the use of 24-h recall data from NHANES 2007-2010 (n = 11,111; >/=19 y).

63 Dietary intake data from NHANES from 2001 to 2010 for adults >/=19 y of age were

64 y (NHANES III) by linking baseline data from NHANES III with the National Death Index.

65 , and pregnant females.We analyzed data from NHANES; toddlers aged 12-23 mo (NHANES 2003-2010), nonpr

66 ions of several PCB congeners decreased from NHANES 2003/04 through 2007/08.

67 ted against national estimates directly from NHANES 2009-2012.

68 Turkey consumption was estimated from NHANES data to estimate daily arsenic exposures for adul

69 tent with national prevalence estimates from NHANES 2009-2012.

70 art rate; and PR, QRS, and QT intervals from NHANES I.

71 cross-sectional analysis were obtained from NHANES 2005-2006.

72 y of the chemical/health co-occurrences from NHANES that are higher than expected by chance.

73 rstood and cannot be estimated reliably from NHANES alone.

74 revalence of childhood obesity: results from NHANES, 2007-2010.

75 Serum specimens from NHANES participants 6-19 years old were tested for EBV a

76 ere measured in plasma in 1613 subjects from NHANES 1999-2000 and 2462 subjects from NHANES 2009-2010

77 from NHANES 1999-2000 and 2462 subjects from NHANES 2009-2010 by gas chromatography-mass spectrometry

78 s and also than Mexican American values from NHANES III (Third National Health and Nutrition Examinat

79 Adults aged 18 to 69 years from NHANES (National Health and Nutrition Examination Survey

80 Health and Nutrition Examination Survey (HTN(NHANES)).

81 Health and Nutrition Examination Survey III (NHANES-III), a nationally representative cross-sectional

82 In NHANES, flexural eczema in the past year was associated

83 In NHANES, participants with glaucoma had significantly hig

84 ion rate >/= 60 mL.min(-)(1).1.73 m(-)(2) in NHANES (adjusted hazard ratio, 1.42; 95% confidence inte

85 The 3136 US adults in NHANES (2007-2012) aged 40 to 65 years represented 100.1

86 ukocyte telomere length among U.S. adults in NHANES, 2001-2002.

87 menopause among women 20-65 years of age in NHANES (National Health and Nutrition Examination Survey

88 More recently, iron status assessment in NHANES has used the total body iron stores (TBI) model,

89 ith Dutch Lipid Clinic criteria available in NHANES, affects 1 in 250 US adults.

90 r occupational factor variables available in NHANES.

91 ith increased urine total arsenic and DMA in NHANES 2003-2010, reflecting arsenic exposure.

92 take of US children aged 6-23 mo examined in NHANES 2009-2012 and compared them to age-specific DRIs

93 Data included individuals in NHANES 2003-2004 to 2009-2010 (children: n = 13,422; adu

94 opulation represented by 3416 individuals in NHANES, the median weighted age was 53 years (interquart

95 37.8 mumol/L (95% CI: 36.4, 39.4 mumol/L) in NHANES 1999-2000 and 2009-2010, respectively.

96 entrations of tri- to hexaBDEs were lower in NHANES 2007/08 than in 2003/04; however, most confidence

97 ow that TFA concentrations were 54% lower in NHANES 2009-2010 than in NHANES 1999-2000.

98 tality risk among seriously ill obese men in NHANES III.

99 mortality risk of obesity was found only in NHANES III and only among men with a wide variety of pre

100 ime, non-Hispanic Asians were oversampled in NHANES.

101 ng adults (aged 18-25 y) who participated in NHANES III (1988-1994) were analyzed.

102 thma in children and adults participating in NHANES 2005-2006.

103 es" and "CS desserts/sweeteners" patterns in NHANES.

104 , and osteoporosis in the U.S. population in NHANES 2009-2010.

105 oup of fasted adults in the US population in NHANES samples from 1999-2000 and 2009-2010.Four major T

106 lates exposures among the U.S. population in NHANES, 2003-2010.

107 is subgroup, the relative mortality risks in NHANES I, II, and III were 2.22 (95% CI: 1.45, 3.40), 0.

108 ed prevalence of HCV antibody was similar in NHANES 2007-2010 (1.5%) and HCHS/SOL (2.0%) but differed

109 88 to 2006, the assessment of iron status in NHANES was based on the multi-indicator ferritin model.

110 and noncivilian persons are not surveyed in NHANES.

111 s were 54% lower in NHANES 2009-2010 than in NHANES 1999-2000.

112 For the first time in NHANES history, sufficient numbers of non-Hispanic Asian

113 pregnant, nonlactating women aged >/=19 y in NHANES 2011-2012, a nationally representative, cross-sec

114 Using multivariable linear (NHANES) and random-effects (Homescan) models, we investi

115 ed data from NHANES; toddlers aged 12-23 mo (NHANES 2003-2010), nonpregnant females aged 15-49 y (NHA

116 imates were weighted based on the multistage NHANES sampling design.

117 from the most recent 2 years (2013-2014) of NHANES and data from 21,013 participants in previous NHA

118 pirical accuracy of 0.5-0.7% on the basis of NHANES data.

119 CI: 2.24 to 7.34) than the control group of NHANES participants.

120 n aged 50 years old or above participants of NHANES III with elevated IgA anti-tTG antibodies had inc

121 alysis included 27,468 adult participants of NHANES of which 363 tested positive for CHC.

122 d and adopted to allow the full potential of NHANES to be realized.

123 n model combined indirect standardization of NHANES-based prevalence with logistic regression modelin

124 inferred exposure for demographic subsets of NHANES demarked by age, gender, and weight using chemica

125 This article demonstrates growing use of NHANES chemical biomarker data in studies that can impac

126 cal accuracy of the equation with the use of NHANES data and performed a comparative analysis with pa

127 iomarkers in Asians with those of four other NHANES race/ethnic groups (white, black, Mexican America

128 es more frequently than NHANES participants, NHANES participants had more restored surfaces, especial

129 ve prevalence of VZV was 2.2% for the pooled NHANES sample.

130 nd data from 21,013 participants in previous NHANES surveys from 2005 through 2012.

131 Results: NHANES included completed clinical evaluations from mobi

132 ticle highlights a) the extent to which U.S. NHANES chemical biomarker data have been evaluated, b) g

133 ormed to identify publications in which U.S. NHANES data were reported.

134 A small percentage of the sampled NHANES-related publications reported on chemical biomark

135 In the cross-sectional NHANES, serum and red blood cell (RBC) folate were first

136 Setting: NHANES (National Health and Nutrition Examination Survey

137 Seven NHANES cycles were included (1999-2000 to 2011-2012), an

138 re: nonsmoking workers in the United States (NHANES 2001-2010).

139 mong Asian populations in the United States: NHANES 2011-2012.

140 mong Asian populations in the United States: NHANES 2011-2012.

141 onal Health and Nutrition Examination Study (NHANES III) cohort, which included 13,504 participants w

142 onal Health and Nutrition Evaluation Survey (NHANES) 1988-1994 dataset found a relatively high seropr

143 nal Health and Nutrition Examination Survey (NHANES 2003-2010).

144 nal Health and Nutrition Examination Survey (NHANES 2005-2006) participants >/= 12 years old (n = 2,8

145 nal Health and Nutrition Examination Survey (NHANES I) cohort (1971-1975) and 6329 from the NHANES II

146 nal Health and Nutrition Examination Survey (NHANES III) by linking baseline data from NHANES III wit

147 nal Health and Nutrition Examination Survey (NHANES III) were linked to Centers for Medicare & Medica

148 nal Health and Nutrition Examination Survey (NHANES III).

149 nal Health and Nutrition Examination Survey (NHANES) (1999-2006).

150 nal Health and Nutrition Examination Survey (NHANES) (n = 4970) and 2010 (n = 27 157) and 2012 (n = 3

151 nal Health and Nutrition Examination Survey (NHANES) (n = 7,252), statistically adjusting for immune

152 nal Health and Nutrition Examination Survey (NHANES) 1999 to 2004.

153 nal Health and Nutrition Examination Survey (NHANES) 1999-2004, we examined cross-sectional associati

154 nal Health and Nutrition Examination Survey (NHANES) 1999-2004.

155 nal Health and Nutrition Examination Survey (NHANES) 1999-2006.

156 nal Health and Nutrition Examination Survey (NHANES) 2001-2002 general U.S. population, this populati

157 nal Health and Nutrition Examination Survey (NHANES) 2003-2004 and 2009-2010 pooled survey cycles.

158 nal Health and Nutrition Examination Survey (NHANES) 2005-2006 (n=6,254) and the Agricultural Lung He

159 nal Health and Nutrition Examination Survey (NHANES) 2005-2006 provides the most comprehensive inform

160 nal Health and Nutrition Examination Survey (NHANES) 2005-2006.

161 nal Health and Nutrition Examination Survey (NHANES) 2007-2008.

162 nal Health and Nutrition Examination Survey (NHANES) 2007-2010 and 11 964 from the Hispanic Community

163 nal Health and Nutrition Examination Survey (NHANES) 2009-2010.

164 nal Health and Nutrition Examination Survey (NHANES) 2009-2012, population counts from the 2010 US ce

165 nal Health and Nutrition Examination Survey (NHANES) 2011 to 2012 were analyzed.

166 nal Health and Nutrition Examination Survey (NHANES) 2011-2012.

167 nal Health And Nutrition Examination Survey (NHANES) 2013-14, a cross-sectional survey of the US popu

168 l Health and Nutritional Examination Survey (NHANES) 2013-2014.

169 nal Health and Nutrition Examination Survey (NHANES) and derive human first-order elimination rate co

170 nal Health and Nutrition Examination Survey (NHANES) and NHANES III (1988-1994).

171 nal Health and Nutrition Examination Survey (NHANES) between 1999 and 2008 with recorded near visual

172 nal Health and Nutrition Examination Survey (NHANES) cohort.

173 nal Health and Nutrition Examination Survey (NHANES) collected between 1999 and 2012.

174 nal Health and Nutrition Examination Survey (NHANES) cycles (1999-2012).

175 nal Health and Nutrition Examination Survey (NHANES) cycles in order to assess the exposure to these

176 nal Health and Nutrition Examination Survey (NHANES) data (2009-2014) were used to assess statin elig

177 nal Health and Nutrition Examination Survey (NHANES) database.

178 nal Health and Nutrition Examination Survey (NHANES) during 2005/06 and 2007/08.

179 nal Health and Nutrition Examination Survey (NHANES) food ingestion rates.

180 nal Health and Nutrition Examination Survey (NHANES) from 1999 to 2010 (in 2-year survey waves).

181 nal Health and Nutrition Examination Survey (NHANES) from 1999-2012.

182 nal Health and Nutrition Examination Survey (NHANES) from 2003 to 2004, but typically higher than the

183 nal Health and Nutrition Examination Survey (NHANES) III (1988-1992) were available for 6032 individu

184 nal Health and Nutrition Examination Survey (NHANES) III (1988-1994) and NHANES 9908 (1999-2008) with

185 nal Health and Nutrition Examination Survey (NHANES) III and NHANES 1999 to 2004.

186 nal Health and Nutrition Examination Survey (NHANES) III.

187 nal Health and Nutrition Examination Survey (NHANES) in five two-year waves from 1999-2008 including

188 nal Health and Nutrition Examination Survey (NHANES) indicate that about 3.6 million people in the Un

189 nal Health and Nutrition Examination Survey (NHANES) indicated approximately 3.6 million noninstituti

190 nal Health and Nutrition Examination Survey (NHANES) participants >/=20 years of age (n=36 949) were

191 nal Health and Nutrition Examination Survey (NHANES) population.

192 nal Health and Nutrition Examination Survey (NHANES) samples a representative cross-section of the US

193 nal Health and Nutrition Examination Survey (NHANES) that included 30,673 children and adolescents.

194 nal Health and Nutrition Examination Survey (NHANES) to compare self-reported SLT use with serum conc

195 nal Health and Nutrition Examination Survey (NHANES) to identify combinations of chemicals that frequ

196 nal Health and Nutrition Examination Survey (NHANES) were used to develop mathematical models of sexu

197 nal Health and Nutrition Examination Survey (NHANES) who had complete data available (n = 14142), rep

198 nal Health and Nutrition Examination Survey (NHANES) who were evaluated for the presence or absence o

199 nal Health and Nutrition Examination Survey (NHANES) with BTEXS and 2,5-dimethylfuran signatures deri

200 nal Health and Nutrition Examination Survey (NHANES) with data from the USDA Food Composition Intake

201 nal Health and Nutrition Examination Survey (NHANES) with urine arsenic available and undetectable ur

202 nal Health and Nutrition Examination Survey (NHANES), 1988-1994, with up to 23 years of linked-mortal

203 nal Health and Nutrition Examination Survey (NHANES), 1999-2002, and the National Health and Aging Tr

204 nal Health and Nutrition Examination Survey (NHANES), a cross-sectional, nationally representative he

205 l Health and Nutritional Examination Survey (NHANES), including full-mouth, six-site periodontal prob

206 nal Health and Nutrition Examination Survey (NHANES), we examined HSV-1 and HSV-2 seroprevalence amon

207 nal Health and Nutrition Examination Survey (NHANES).

208 nal Health and Nutrition Examination Survey (NHANES).

209 nal Health and Nutrition Examination Survey (NHANES).

210 nal Health and Nutrition Examination Survey (NHANES).

211 nal Health and Nutrition Examination Survey (NHANES).

212 nal Health and Nutrition Examination Survey (NHANES).

213 nal Health and Nutrition Examination Survey (NHANES).

214 nal Health and Nutrition Examination Survey (NHANES).

215 nal Health and Nutrition Examination Survey (NHANES).

216 nal Health and Nutrition Examination Survey (NHANES).

217 nal Health and Nutrition Examination Survey (NHANES).

218 nal Health and Nutrition Examination Survey (NHANES).

219 nal Health and Nutrition Examination Survey (NHANES): 1988-1994 (21,260 persons); 1999-2008 (29,828);

220 nal Health and Nutrition Examination Survey (NHANES); mean concentrations of most PFASs declined from

221 nal Health and Nutrition Examination Survey (NHANES: 2001-2010).

222 nal Health and Nutrition Examination Survey (NHANES; 2005-2010; n = 9,316), an ongoing nationally rep

223 nal Health and Nutrition Examination Survey [NHANES]; n = 1,192).

224 al Health and Nutrition Examination Surveys (NHANES III, 1999 to 2002, and 2007 to 2008).

225 al Health and Nutrition Examination Surveys (NHANES) (2005-2006 and 2007-2008).

226 al Health and Nutrition Examination Surveys (NHANES) 1988 to 1994, 1999 to 2004, and 2005 to 2010 wer

227 Health and Nutritional Examination Surveys (NHANES) 2009-2012.

228 al Health and Nutrition Examination Surveys (NHANES) and evaluated interactions between these variant

229 al Health and Nutrition Examination Surveys (NHANES) for the United States and for 1060 adults aged 4

230 Health and Nutritional Examination Surveys (NHANES), which include detailed information on HRBs and

231 missing dental surfaces more frequently than NHANES participants, NHANES participants had more restor

232 The NHANES collects comprehensive cross-sectional data on th

233 The NHANES comprised 2975 respondents aged 60 years and olde

234 The NHANES measured Digit Symbol Substitution Test (DSST) sc

235 The NHANES was composed of a civilian, noninstitutionalized

236 Biomonitoring surveys, such as the NHANES (National Health and Nutrition Examination Survey

237 duals aged 17 to 21 years represented by the NHANES sample, 483 500 (95% CI, 482 100-484 800) young p

238 Comparing the NHANES regression results with those from the literature

239 e 30,298 adult respondents who completed the NHANES during 2003-2010, 418 reported having exclusively

240 This article describes the NHANES program and data from NHANES 1999-2010 on young c

241 During the NHANES 2013-2014, a total of 1868 men aged 18 to 59 year

242 ned in mobile examination centers during the NHANES 2013-2014.

243 equal to 71% x 75% of those selected for the NHANES)] collected a complete initial 24-h specimen and

244 Individuals from the NHANES 2003-2004 survey were stratified based on occupat

245 en (aged 7-11 mo, 1-3 y, and 4-5 y) from the NHANES 2003-2010 by using measurement error models.

246 Data from the NHANES 2003-2010 were used to examine food sources of so

247 ld by using 1-d dietary recall data from the NHANES 2007-2010.

248 hemical-health impact relationships from the NHANES biomonitoring survey studies.

249 mortality-linked water intake data from the NHANES conducted in 1988-1994 and 1999-2004 for this pro

250 ANES I) cohort (1971-1975) and 6329 from the NHANES III cohort (1988-1994).

251 llion-1.8 million) persons excluded from the NHANES sampling frame have hepatitis C virus antibody, i

252 f hepatitis C that are not excluded from the NHANES sampling frame, were not addressed in this study.

253 sex, race/ethnicity, and BMI category in the NHANES (National Health and Nutrition Examination Survey

254 e dietary data who were participating in the NHANES 2003-2006.

255 nts are linked to adult MVMs reported in the NHANES 2003-2008 via the Dietary Supplement Ingredient D

256 were deemed feasible and implemented in the NHANES 2014 on a subsample of adults aged 20-69 y to ass

257 at distance, near, and by self-report in the NHANES and by self-report alone in the NHATS.

258 ight, height, and BMI flagged as BIVs in the NHANES are very likely correct.

259 sis of 45,754 adults who participated in the NHANES from 1988-1994 through 2009-2010.

260 hildren and adolescents, aged 2-18 y, in the NHANES from 1999 to 2012 were included.

261 were the most significant ECG factors in the NHANES I cohort.

262 The equation was evaluated in the NHANES III cohort for an independent validation.

263 Follow-up in the NHANES III cohort was completed on December 31, 2006.

264 on of individuals aged 17 to 21 years in the NHANES population who were eligible for statin therapy,

265 6338 young people aged 17 to 21 years in the NHANES population, 2.5% (95% CI, 1.8%-3.2%) would qualif

266 In the NHANES, current history of asthma (1.33; 1.04-1.70; P =

267 In the NHANES, distance VI (beta = -5.1; 95% CI, -8.6 to -1.6;

268 valence of obesity in 2- to 19-y-olds in the NHANES, which is a study in which extreme values were ve

269 by hemoglobin levels for age and sex in the NHANES.

270 10-fold change in endotoxin; p=0.004) in the NHANES.

271 with age and sex, were incorporated into the NHANES ECG risk equation.

272 Analyses of the NHANES 2003-2008 show that processed foods provide both

273 Using the 2005-2008 waves of the NHANES as a model of population-based screening for eye

274 Approximately 25% of the NHANES population was not able to successfully complete

275 participants in the 2005-2008 cycles of the NHANES, which evaluated a sample of the noninstitutional

276 ated in a 24-h dietary recall as part of the NHANES, which is a nationally representative survey of t

277 h (OR = 2.08; 95% CI: 1.29 to 2.79) than the NHANES participants.

278 ere is now interest in further utilizing the NHANES data to inform chemical risk assessments.

279 Using data obtained within the NHANES 2009-2010 survey, where a high performance assay

280 ted and controlled hypertension according to NHANES criteria in DETECT remained low between 2001 and

281 When applied to NHANES data, these models provide a sustainable method f

282 odel predictions, and models were applied to NHANES serum data to predict milk PBDE concentrations an

283 Results were compared to NHANES 2003-04.

284 ooled concentrations have been contrasted to NHANES 2003/04 individual measurements to evaluate chang

285 studies are addressing challenges related to NHANES data interpretation in health risk contexts.

286 ed the following 4 different studies: The US NHANES 1999-2004, Comprehensive Assessment of Long-term

287 om nationally representative surveys: the US NHANES 2011-2012 (n = 7456) and the French Individual an

288 ere >95th percentile from children in the US NHANES III, and 13% of children had hypercarotenemia (de

289 Analyses were stratified by gender and used NHANES sample weights.

290 voluntary sodium standards for foods.We used NHANES 2007-2010 data for 17,933 participants aged >/=1

291 We used NHANES sampling weights to estimate the population preva

292 Three validation cohorts were used: NHANES (2009 to 2010 and 2011 to 2012) and the Piedmont

293 Using NHANES definitions, DME and CSME prevalences from monocu

294 periodontal disease in young adults by using NHANES III data.

295 A cross-sectional study was conducted using NHANES data from the 2009 to 2012 examination cycle.

296 s by 3 trained and calibrated dentists using NHANES protocols.

297 With NHANES, we compared survey-weighted energy intakes for 2

298 similar TDS food and used these, along with NHANES food intake data, to develop 4 estimates of each

299 Compared with NHANES participants, HCT survivors (median age, 55.9 yea

300 07-2010), and pregnant females aged 12-49 y (NHANES 1999-2010).

301 003-2010), nonpregnant females aged 15-49 y (NHANES 2007-2010), and pregnant females aged 12-49 y (NH